Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avi Caspi

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of the American College of Cardiology|January 22, 2003
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled studyEdo Kaluski, Isaac Kobrin, Reuven Zimlichman, et al.
Journal of Neural Engineering|January 26, 2026
Autonomous multisensory enhancement of a visual neuroprosthesis for navigation: Technical proof-of-concept with simulated prosthetic vision and single-subject case study of a visual prosthesis userBreanne Christie, Nicolas Norena Acosta, Roksana Sadeghi, et al.
Archives of Internal Medicine|August 16, 2006
Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failureAlon Barsheshet, Moshe Garty, Ehud Grossman, et al.
JACC. Heart Failure|April 29, 2017
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE TrialsMilton Packer, John J V McMurray, Henry Krum, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 8, 2009
Preliminary 6 month results from the Argus II epiretinal prosthesis feasibility studyMark S Humayun, Jessy D Dorn, Ashish K Ahuja, et al.
American Heart Journal|April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyGad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of the American College of Cardiology|January 22, 2003
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled studyEdo Kaluski, Isaac Kobrin, Reuven Zimlichman, et al.
Journal of Neural Engineering|January 26, 2026
Autonomous multisensory enhancement of a visual neuroprosthesis for navigation: Technical proof-of-concept with simulated prosthetic vision and single-subject case study of a visual prosthesis userBreanne Christie, Nicolas Norena Acosta, Roksana Sadeghi, et al.
Archives of Internal Medicine|August 16, 2006
Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failureAlon Barsheshet, Moshe Garty, Ehud Grossman, et al.
JACC. Heart Failure|April 29, 2017
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE TrialsMilton Packer, John J V McMurray, Henry Krum, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 8, 2009
Preliminary 6 month results from the Argus II epiretinal prosthesis feasibility studyMark S Humayun, Jessy D Dorn, Ashish K Ahuja, et al.
American Heart Journal|April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyGad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
Pageof 4